IMMUNITYBIO, INC. (IBRX) Debt Components
- 2026-03-31: Debt, CurrentUSD $884.00K; Debt Instrument, Convertible, Conversion PriceUSD/shares (m); Notes Payable, CurrentUSD (m); Notes PayableUSD (m).
- 2025-12-31: Debt, CurrentUSD $1.75M; Debt Instrument, Convertible, Conversion PriceUSD/shares (m); Notes Payable, CurrentUSD (m); Notes PayableUSD (m).
- 2025-09-30: Debt, CurrentUSD $2.60M; Debt Instrument, Convertible, Conversion PriceUSD/shares (m); Notes Payable, CurrentUSD (m); Notes PayableUSD (m).
- 2024-12-31: Debt, CurrentUSD $1.25M; Debt Instrument, Convertible, Conversion PriceUSD/shares (m); Notes Payable, CurrentUSD (m); Notes PayableUSD (m).
IMMUNITYBIO, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Debt, Current USD | Debt Instrument, Convertible, Conversion Price USD/shares | Notes Payable, Current USD | Notes Payable USD | Long-term Debt and Lease Obligation, Including Current Maturities USD | Debt Instrument, Periodic Payment, Interest USD | Debt Instrument, Periodic Payment, Principal USD | Debt Instrument, Increase, Accrued Interest USD | Debt Instrument, Unamortized Discount USD | Notes Payable, Related Parties USD | Notes Payable, Related Parties, Current USD | Notes Payable, Related Parties, Noncurrent USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $884.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $1.75M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $2.60M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $1.25M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-30 | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-09-11 | (m) | 1.29 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | $481.89M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $52.67M | $717.12M | (m) | (m) |
| 2022-12-31 | (m) | (m) | $431.90M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $64.21M | $673.17M | (m) | (m) |
| 2022-12-12 | (m) | 5.67 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $79.68M | $661.05M | (m) | (m) |
| 2022-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $612.62M | $300.08M | $312.54M |
| 2022-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $609.04M | $299.61M | $309.43M |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $1.44M | $605.59M | (m) | (m) |
| 2021-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $299.24M | $306.35M |
| 2021-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $303.24M |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $300.25M |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $297.29M |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $254.35M | $0.00 | $254.35M |
| 2020-12-31 | (m) | (m) | (m) | (m) | $1.42M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2019-12-31 | (m) | (m) | (m) | (m) | $757.00K | (m) | (m) | (m) | (m) | $181.62M | (m) | (m) |
| 2015-09-30 | (m) | (m) | (m) | (m) | (m) | 9 month · $13.00K | 9 month · $29.00K | 9 month · $50.00K | (m) | (m) | (m) | (m) |
| 2015-06-30 | (m) | (m) | (m) | (m) | (m) | 6 month · $13.00K | 6 month · $29.00K | 6 month · $50.00K | (m) | (m) | (m) | (m) |
| 2014-12-31 | (m) | (m) | $265.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-04-30 | (m) | (m) | (m) | $1.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kymera Therapeutics, Inc. (KYMR) | United States | $9.631B | -31.69 |
| Vaxcyte, Inc. (PCVX) | United States | $8.466B | -7.91 |
| Krystal Biotech, Inc. (KRYS) | United States | $10.210B | 45.56 |
| REPLIGEN CORP (RGEN) | United States | $10.755B | 185.31 |
| Immunovant, Inc. (IMVT) | United States | $7.028B | -14.78 |
| BIO-TECHNE Corp (TECH) | United States | $11.379B | 74.68 |
| Twist Bioscience Corp (TWST) | United States | $11.540B | -47.21 |
| CG Oncology, Inc. (CGON) | United States | $6.095B | -27.95 |
| Scholar Rock Holding Corp (SRRK) | United States | $5.920B | -16.37 |
| CRISPR Therapeutics AG (CRSP) | $5.390B | -11.68 |